Chemistry:Gadofosveset

From HandWiki
Revision as of 12:24, 26 June 2023 by OrgMain (talk | contribs) (url)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Gadofosveset trisodium
Gadofosveset skeletal.svg
Clinical data
Trade namesVasovist, Ablavar
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
Intravenous
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
Chemical and physical data
FormulaC33H40GdN3Na3O15P
Molar mass975.88 g·mol−1
3D model (JSmol)

Gadofosveset (trade names Vasovist, Ablavar) is a gadolinium-based MRI contrast agent. It was used as the trisodium salt monohydrate form.[1][2] It acts as a blood pool agent by binding to human serum albumin. The manufacturer (Lantheus Medical) discontinued production in 2017 due to poor sales.[3]

Gadofosveset facilitates high-resolution magnetic resonance angiography.[4] Ferumoxytol (trade names Feraheme, Rienso), an intravenous iron-replacement therapy, has been shown to potentially be superior to gadofosveset as a blood pool agent for MR venography in pediatric patients.[5]

References

  1. DailyMed: Vasovist
  2. Drugs.com: Ablavar
  3. "Gadofosveset trisodium". radiopaedia.org. https://radiopaedia.org/articles/gadofosveset-trisodium-1. 
  4. "Gadofosveset trisodium: abdominal and peripheral vascular applications". AJR. American Journal of Roentgenology 200 (6): 1378–86. June 2013. doi:10.2214/AJR.12.8991. PMID 23701079. 
  5. "High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol". Pediatric Radiology 52 (3): 501–512. March 2022. doi:10.1007/s00247-021-05225-2. PMID 34936018.